5Rachner TD.Khosla S.Hofbauer LC.Osteoporosis:now and the future[J].TheLancet ,2011 , 377(9773): 1276-1287. 被引量:1
6Das S, Crockett JC. Osteoporosis .a current view of pharmacologicalprevention and treatment[J].Drug Des Devel Ther,2013,31(7);435-448. 被引量:1
7Wu YP,Chen WS,Xu SJ,et al .Osteoporosis as a potential contributor tothe bone metastases[J].Med Hypotheses,201 0,75(6).514-51 6. 被引量:1
8Senel K,Baykal T,Seferoglu B,et al.Circulating vascular endothelialgrowth factor concentrations in patients with postmenopausalosteoporosis[J],Arch Med Sci,201 3,9(4);709-71 2. 被引量:1
9Kashiwagi H , Ono Y, Ohta M,et al. A series of nonsecosteroidalvitamin D receptor agonists for osteoporosis therapy[J], Bioorg MedChem,2013,21(7): 1823-1833. 被引量:1